News
August 4, 2014

Is Valeant’s Offer for Allergan the New Roadmap for Biopharma Acquisitions?

Pharmaceutical Compliance Monitor publishes “Is Valeant’s Offer for Allergan the New Roadmap for Biopharma Acquisitions?”, written by Partner Nicholas O’Keefe.

People

Subscribe
Subscribe Link

Email Disclaimer